44
Participants
Start Date
February 18, 2020
Primary Completion Date
February 28, 2026
Study Completion Date
July 31, 2026
Celecoxib
Patients will receive celecoxib 200 mg PO BID for 7 days post endoscopic sinus surgery, starting on the evening of the day of surgery.
Placebo
Patients will receive placebo PO BID for 7 days post endoscopic sinus surgery, starting on the evening of the day of surgery.
St. Joseph's Healthcare London, London
King Abdulaziz University Hospital, Jeddah
Collaborators (1)
Western University, Canada
OTHER
London Health Sciences Centre
OTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER